TORONTO, March 20, 2019 /CNW/ - William Wells, Executive Chairman, alongside Greg Gubitz, CEO, HLS Therapeutics Inc. (HLS), joined joined Dani Lipkin, Innovation Sector Head, Capital Formation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Formed in 2015, HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS Therapeutics Inc. graduated and commenced trading on Toronto Stock Exchange on February 7, 2019.
SOURCE TMX Group Limited
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/20/c2441.html
Copyright CNW Group 2019